NCT05054309

A Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome

Name: Clinical Trial NCT05054309
Creator: Nestlé
Keywords: IBS - Irritable Bowel Syndrome, Bifidobacterium longum, dietary supplement, clinical trial, Canada

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Bifidobacterium Longum NCC3001 on Intestinal and Psychological Symptoms in Subjects With Irritable Bowel Syndrome

Nestlé·ClinicalTrials.gov·dietary supplementRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: IBS - Irritable Bowel Syndrome
Drug/Device/Intervention: Bifidobacterium longum
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Nestlé
Location: North Bay,Sudbury,Toronto,Victoria, Canada

Timeline & enrollment

Phase: N/A
Start date: Feb 11, 2022
End date: Jul 31, 2023
Enrollment: 184 participants

Primary outcome

To evaluate the effect of Bifidobacterium Longum (BL NCC3001) on Gastrointestinal Symptoms,To evaluate the effect of Bifidobacterium Longum (BL NCC3001) on Psychological Symptoms

Summary

This is a prospective, randomized, placebo-controlled, double-blind, multi-center parallel- design study to evaluate the effect of BL NCC3001 in subjects with Irritable Bowel Syndrome.

ICD-10 classifications

Irritable bowel syndrome with predominant constipation [IBS-C]Irritable bowel syndromeIrritable bowel syndrome with predominant diarrhoea [IBS-D]Irritable bowel syndrome with mixed bowel habits [IBS-M]Other and unspecified irritable bowel syndrome

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05054309
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05054309 through Pure Global AI's free database. This phase not specified trial is sponsored by Nestlé and is currently Recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 184 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.